Minimizing Leukemia Relapse: A Phase I, Dose Escalation Study of Decitabine in High Risk Pediatric Leukemia Post Allogeneic Transplant
Phase of Trial: Phase I
Latest Information Update: 22 Oct 2018
Price : $35 *
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 12 Oct 2018 Status changed from active, no longer recruiting to completed.
- 29 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 02 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.